Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

134.75
0.0000
Pre-market: 134.38-0.3700-0.27%04:02 EDT
Volume:948.28K
Turnover:127.82M
Market Cap:10.15B
PE:-31.05
High:134.82
Open:134.79
Low:134.70
Close:134.75
52wk High:134.88
52wk Low:35.39
Shares:75.34M
Float Shares:58.14M
Volume Ratio:0.68
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3400
EPS(LYR):-4.2155
ROE:-32.46%
ROA:-20.30%
PB:8.50
PE(LYR):-31.97

Loading ...

Apogee Therapeutics downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Jun 24

Apogee Therapeutics (APGE) was downgraded to a Hold Rating at TD Cowen

TIPRANKS
·
Jun 24

Apogee Therapeutics' Acquisition by AbbVie Fairly Values Zumilokibart, UBS Says

MT Newswires Live
·
Jun 23

Apogee Therapeutics Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Jun 23

Apogee Therapeutics downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Jun 23

Apogee Therapeutics moved to No Rating at BofA

TIPRANKS
·
Jun 23

Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jun 23

Apogee Therapeutics, Inc. : Deutsche Bank Raises Target Price to $135 From $116

THOMSON REUTERS
·
Jun 23

Apogee Therapeutics, Inc. : Deutsche Bank Cuts to Hold From Buy

THOMSON REUTERS
·
Jun 23

RBC Removes 'Speculative Risk' From Apogee Therapeutics, Raises Price Target to $135 From $97 Amid AbbVie Deal, Keeps Sector Perform Rating

MT Newswires Live
·
Jun 23

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys

Reuters
·
Jun 23

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics — and Why the Stock Rises 47%

Dow Jones
·
Jun 23

Apogee deal gives positive readthrough to Evommune pipeline, says Clear Street

TIPRANKS
·
Jun 23

Top Midday Gainers

MT Newswires Live
·
Jun 23

US STOCKS-S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched

Reuters
·
Jun 23

Apogee Therapeutics rises 46.8%

TIPRANKS
·
Jun 23

Top Midday Stories: Treasury Authorizes Sale of Iranian Oil; SpaceX launches First Inaugural Bond Issuance

MT Newswires Live
·
Jun 22

Apogee Therapeutics downgraded to Neutral from Outperform at Wedbush

TIPRANKS
·
Jun 22

Apogee Therapeutics Inc : Wedbush Cuts to Neutral From Outperform

THOMSON REUTERS
·
Jun 22

Apogee Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jun 22